Yifeng Pharmacy Chain (603939.SH) disclosed its semi-annual report for 2024, and the company achieved revenue of...
According to the semi-annual report for 2024 disclosed by Yifeng Pharmacy Chain (603939.SH), the company achieved revenue of 11.762 billion yuan, a year-on-year growth of 9.86%. The net income attributable to shareholders of the listed company was 0.798 billion yuan, a year-on-year growth of 13.13%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.786 billion yuan, a year-on-year growth of 15.77%. The basic earnings per share is 0.66 yuan/share. The proposed cash dividend per share is 0.25 yuan (including tax).
